Eriko Hiruta

Real-World Patient Characteristics and Treatment Patterns of Naldemedine for the Treatment of Opioid-Induced Constipation in Patients with Cancer: A Multicenter Retrospective Chart Review Study

S. Takei, M. Kotake, S. Koizuka, 2021, Medicina.

A retrospective study of the efficacy and safety of naldemedine for opioid‐induced constipation in thoracic cancer patients

K. Kaira, H. Imai, K. Minato, 2022, Thoracic cancer.

Efficacy and Safety of Naldemedine for Patients with Cancer with Opioid-Induced Constipation in Clinical Practice: A Real-World Retrospective Study

H. Imai, K. Minato, M. Matsuura, 2022, Journal of clinical medicine.

A Retrospective Study of the Efficacy and Safety of Naldemedine for Treatment of Opioid-Induced Constipation in Patients with Hepatobiliary Pancreatic Cancer

K. Kaira, S. Koizuka, H. Imai, 2023, Medicina.

Efficacy and Safety of Naldemedine Administration for Opioid-Induced Constipation in Cancer Patients with Poor Performance Status.

K. Kaira, S. Koizuka, H. Imai, 2023, Journal of palliative medicine.

Effects of Sex and Seasonal Climatic Changes on the Risk of Incidence of Anti-EGFR Therapy-Induced Rash in Cancer Patients: A Retrospective Study

H. Ojima, H. Hosaka, H. Imai, 2021, Medicina.

Effects of Sex and Weather on the Risk of Incidence of Anti-EGFR Therapy-Induced Rash in Cancer Patients: A Retrospective Study.

H. Ojima, H. Hosaka, H. Imai, 2021 .